239 related articles for article (PubMed ID: 22333393)
1. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.
Johansson I; Nilsson C; Berglund P; Lauss M; Ringnér M; Olsson H; Luts L; Sim E; Thorstensson S; Fjällskog ML; Hedenfalk I
Breast Cancer Res; 2012 Feb; 14(1):R31. PubMed ID: 22333393
[TBL] [Abstract][Full Text] [Related]
2. miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.
Endo Y; Toyama T; Takahashi S; Yoshimoto N; Iwasa M; Asano T; Fujii Y; Yamashita H
Endocr Relat Cancer; 2013 Feb; 20(1):91-102. PubMed ID: 23183268
[TBL] [Abstract][Full Text] [Related]
3. Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes.
Johansson I; Lauss M; Holm K; Staaf J; Nilsson C; Fjällskog ML; Ringnér M; Hedenfalk I
Mol Oncol; 2015 Oct; 9(8):1565-79. PubMed ID: 25990542
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer.
Endo Y; Yamashita H; Takahashi S; Sato S; Yoshimoto N; Asano T; Hato Y; Dong Y; Fujii Y; Toyama T
BMC Cancer; 2014 Dec; 14():990. PubMed ID: 25528056
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of male breast cancer - lost in translation?
Johansson I; Killander F; Linderholm B; Hedenfalk I
Int J Biochem Cell Biol; 2014 Aug; 53():526-35. PubMed ID: 24842109
[TBL] [Abstract][Full Text] [Related]
6. Male breast cancer: Looking for better prognostic subgroups.
Abreu MH; Afonso N; Abreu PH; Menezes F; Lopes P; Henrique R; Pereira D; Lopes C
Breast; 2016 Apr; 26():18-24. PubMed ID: 27017238
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotyping of male breast cancer - Experience at a tertiary care centre.
Pasricha S; Kamboj M; Tanwar P; Gupta G; Panigrahi M; Sharma A; Durga G; Mehta A
Indian J Pathol Microbiol; 2019; 62(2):226-231. PubMed ID: 30971545
[TBL] [Abstract][Full Text] [Related]
8. Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance.
Minchin RF; Butcher NJ
BMC Genomics; 2018 Jul; 19(1):513. PubMed ID: 29969986
[TBL] [Abstract][Full Text] [Related]
9. Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors.
Wakefield L; Robinson J; Long H; Ibbitt JC; Cooke S; Hurst HC; Sim E
Genes Chromosomes Cancer; 2008 Feb; 47(2):118-26. PubMed ID: 17973251
[TBL] [Abstract][Full Text] [Related]
10. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of mitotic index and Bcl2 expression in male breast cancer.
Lacle MM; van der Pol C; Witkamp A; van der Wall E; van Diest PJ
PLoS One; 2013; 8(4):e60138. PubMed ID: 23573235
[TBL] [Abstract][Full Text] [Related]
12. Dachshund 1 is Differentially Expressed Between Male and Female Breast Cancer: A Matched Case-Control Study of Clinical Characteristics and Prognosis.
Cui Q; Kong D; Li Z; Ahiable P; Wang K; Wu K; Wu G
Clin Breast Cancer; 2018 Oct; 18(5):e875-e882. PubMed ID: 29478945
[TBL] [Abstract][Full Text] [Related]
13. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
Li X; Yang J; Krishnamurti U; Huo L; Ward KC; O'Regan R; Peng L
Clin Breast Cancer; 2017 Aug; 17(5):356-366. PubMed ID: 28576631
[TBL] [Abstract][Full Text] [Related]
14. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
[TBL] [Abstract][Full Text] [Related]
15. High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer.
Johansson I; Nilsson C; Berglund P; Strand C; Jönsson G; Staaf J; Ringnér M; Nevanlinna H; Barkardottir RB; Borg A; Olsson H; Luts L; Fjällskog ML; Hedenfalk I
Breast Cancer Res Treat; 2011 Oct; 129(3):747-60. PubMed ID: 21113657
[TBL] [Abstract][Full Text] [Related]
16. Male breast cancer: A closer look at patient and tumor characteristics and factors associated with survival.
Zhao J; Wang B; Zhao J; Mao Y; Liu J; Yang Y
Thorac Cancer; 2020 Nov; 11(11):3107-3116. PubMed ID: 32930510
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism.
Carlisle SM; Trainor PJ; Hong KU; Doll MA; Hein DW
Sci Rep; 2020 Jun; 10(1):9804. PubMed ID: 32555504
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.
Carlisle SM; Hein DW
Int J Oncol; 2018 Aug; 53(2):694-702. PubMed ID: 29901116
[TBL] [Abstract][Full Text] [Related]
19. Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.
Deb S; Jene N; ; Fox SB
BMC Cancer; 2012 Nov; 12():510. PubMed ID: 23146383
[TBL] [Abstract][Full Text] [Related]
20. Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact.
Nilsson C; Johansson I; Ahlin C; Thorstenson S; Amini RM; Holmqvist M; Bergkvist L; Hedenfalk I; Fjällskog ML
Acta Oncol; 2013 Jan; 52(1):102-9. PubMed ID: 22928693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]